We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Issues New Draft Guidance Documents Outlining IDE Decision Pathways; New Policies and Pilot Program for Early Feasibility IDE Studies

23 November 2011

Medical Device Alert

On Thursday, 10 November 2011, the Food and Drug Administration (FDA or "the Agency") issued two draft guidance documents, one regarding the range of potential pathways and FDA decision-making for investigational device exemption (IDE) applications, and one discussing the Agency's approach and new policies regarding early feasibility IDE studies.

Read "FDA Issues New Draft Guidance Documents Outlining IDE Decision Pathways; New Policies and Pilot Program for Early Feasibility IDE Studies"

The team

Loading data